— Gregory Poland, MD, advocates both vaccination and better understanding of possible side effect by Jennifer Henderson Gregory Poland, MD, director of the Mayo Clinic's Vaccine Research Group in Rochester, Minnesota, remains a steadfast vaccination advocate -- even...
— Both groups face scrutiny over long COVID recommendations by Jennifer Henderson IncellDx, a company that's marketing a diagnostic and treatment plan for long COVID, says it's not at all associated with the Front Line COVID-19 Critical Care Alliance (FLCCC) after...
— FLCCC promotes 20 therapies: like "throwing spaghetti against the wall," one expert says by Jennifer Henderson As patients with long COVID scour the internet desperate for relief, physicians are concerned they may stumble upon an unproven treatment plan touted by a...
by Jennifer Henderson Patients Spend Thousands on Long COVID 'Cure' As COVID-19 continues to wreak havoc for many patients long after their initial symptoms subside, some are seeking help in expensive and experimental forms. Mother Jones reported on the case of a...
— Trial website cites supply issues by Jennifer Henderson The ivermectin arm of the U.K.'s PRINCIPLE trial is "currently paused due to temporary supply issues," according to the trial's website. The website does not offer any details on what caused the ivermectin...
— Virginia hospital took issue with article co-authored by Paul Marik, MD by Jennifer Henderson On the same day that one of his papers was retracted, a physician who has been a vocal proponent of ivermectin filed suit against his hospital. Paul Marik, MD,...
— More hospitals see lawsuits from family members of COVID-19 patients seeking the drug by Jennifer Henderson As hospitals continue to admit COVID-19 patients, some are contending with demands from family members to attempt to treat their loved ones with ivermectin....